AMIT SHAH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2020-06-25 Mr. Shah was formally appointed as an employee and appointed as in-house CFO effective August 2, 2019. He earned restricted stock grants and incentive stock options for his services as a consultant CFO.

Data sourced from SEC filings. Last updated: 2025-10-12